ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

CNTA Centessa Pharmaceuticals PLC

10.18
0.25 (2.52%)
15 Jun 2024 - Closed
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Sep 2021Dec 2021Mar 2022Dec 2022Mar 2023Jun 2023
USD (US$)USD (US$)
Total Revenue 00196k000
Operating Income -38.31M-58.29M-53.02M-41.6M-48.88M-47.02M
Pre Tax Income -40.16M-60.66M-54.42M-43.84M-50.04M-48.94M
Net Income -40.16M-60.77M-54.5M-43.17M-50.71M-24.89M
Preferred Dividends 000000
Basic Earnings Per Share (EPS) 000000
EBIT -40.22M-58.29M-53.02M-39.26M-50.22M-48.55M
EBITDA -38.31M-58.26M-53.02M-41.47M-48.79M-46.78M
Year End 31 December 2022 20212022
USD (US$)USD (US$)
Total Revenue 00
Operating Income -374.08M-212.26M
Pre Tax Income -380.96M-216.95M
Net Income -381.07M-216.21M
Preferred Dividends 00
Basic Earnings Per Share (EPS) -4.235-2.28
EBIT -374.08M-209.92M
EBITDA -374.05M-212.13M